[144] WRAP TECHNOLOGIES, INC. SEC Filing

Rhea-AI Filing Summary

WRAP Technologies, Inc. Form 144 notice shows a proposed sale of 794,455 shares of common stock through Charles Schwab with an aggregate market value of $1,859,024.70. The filing reports the shares were acquired in two transactions: 333,334 shares purchased on 10/30/2018 and 461,121 shares from warrant exercise on 06/01/2020, both paid in cash. The filer previously sold 15,000 shares on 07/10/2025 for $22,498.00. The filing includes the required representation that the seller is not aware of undisclosed material adverse information about the issuer.

Positive

• Full provenance disclosed: Acquisition dates, transaction types, and payment method (cash) are provided for all 794,455 shares to be sold
• Broker and sale logistics specified: Broker identified (Charles Schwab) with planned sale date and aggregate market value
• Compliance representation included: Seller certifies no undisclosed material adverse information

Negative

• None.

Insights

Securities/Corporate Transactions Analyst

TL;DR: The filing discloses a planned insider sale of 794,455 shares totaling about $1.86 million, consistent with prior acquisitions and a recent small sale.

The notice documents the provenance of all shares to be sold and shows prior partial disposition (15,000 shares on 07/10/2025). The shares slated for sale match the sum of two historical acquisitions, indicating no complex transfer chains. For investors, this is a routine Rule 144 disclosure: it provides transparency on an insider's liquidity but, on its face, does not state any undisclosed operational issues.

Compliance/Risk Analyst

TL;DR: The filing appears procedurally complete and includes the required insider certification about material information.

The form lists acquisition dates, nature of acquisition, payment method, recent sale activity, broker and intended sale date and market value. The explicit representation that no undisclosed material adverse information is known by the seller addresses a core compliance requirement. There is no evidence in the filing of irregular payment terms or non-cash consideration that would raise additional compliance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Charles Schwab & Co. 3000 Schwab Way Westlake TX 76262	794455	1859024.70	50820698	10/02/2025	NASDAQ CM

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	10/30/2018	Purchase	Issuer			333334	10/30/2018	Cash
Common Stock	06/01/2020	Warrant Exercise	Issuer			461121	06/01/2020	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Elwood G Norris 3480 MAIN HWY, SUITE 202 Miami FL 33133	Common Stock	07/10/2025	15000	22498.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does WRAP's Form 144 disclose about the number of shares to be sold?

The filing discloses a proposed sale of 794,455 shares of WRAP common stock.

What is the aggregate market value of the shares listed on the WRAP Form 144?

The aggregate market value is reported as $1,859,024.70.

How were the 794,455 shares acquired according to the filing?

They were acquired in two transactions: 333,334 shares purchased on 10/30/2018 (cash) and 461,121 shares from warrant exercise on 06/01/2020 (cash).

Has the filer sold any WRAP shares recently before this notice?

Yes, the filing shows a sale of 15,000 shares on 07/10/2025 for $22,498.00.

Through which broker will the WRAP shares be sold and when?

The sale is planned through Charles Schwab & Co. with an approximate sale date of 10/02/2025 on NASDAQ CM.